Diflorasone Diacetate

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Diflorasone Diacetate
Generic name: DIFLORASONE DIACETATE
Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 23eb27a4-157f-4eb5-a390-37586710808f
SPL ID: 0cc31fd1-b6fb-44d0-a911-b4c11ce12c4b
Version: 4
Effective date: 2023-05-02
Source export date: 2026-10-12
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:54:59

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 18 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	207440	derived:openfda.application_number
application number		ANDA207440	openfda.application_number
brand name		Diflorasone Diacetate	openfda.brand_name
generic name		DIFLORASONE DIACETATE	openfda.generic_name
manufacturer name		Rising Pharma Holdings, Inc.	openfda.manufacturer_name
ndc	package	64980-124-45	openfda.package_ndc
ndc	package	64980-124-60	openfda.package_ndc
ndc	package	64980-124-15	openfda.package_ndc
ndc	package	64980-124-03	openfda.package_ndc
ndc	product	64980-124	openfda.product_ndc
ndc11	package	64980012460	derived:openfda.package_ndc
ndc11	package	64980012445	derived:openfda.package_ndc
ndc11	package	64980012415	derived:openfda.package_ndc
ndc11	package	64980012403	derived:openfda.package_ndc
rxcui		966607	openfda.rxcui
spl id		0cc31fd1-b6fb-44d0-a911-b4c11ce12c4b	id
spl set id		23eb27a4-157f-4eb5-a390-37586710808f	set_id
unii		7W2J09SCWX	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions have been reported with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in approximate decreasing order of occurrence: 1. Burning 2. Itching 3. Irritation 4. Dryness 5. Folliculitis 6. Hypertrichosis 7. Acneiform eruptions 8. Hypopigmentation 9. Perioral dermatitis 10. Allergic contact dermatitis 11. Maceration of the skin 12. Secondary infection 13. Skin atrophy 14. Striae 15. Miliaria To report SUSPECTED ADVERSE REACTIONS, contact Rising Pharmaceuticals, Inc. at 1-844-874-7464 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.